SCHEMBL3094411

SCHEMBL3094411

Cc1c(C(=O)NSC(C)C)cnc2cc(C(F)(F)F)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.40
PDE6D O43924 1/20 0.39
PDE5A O76074 1/20 0.39
PDE6A P16499 1/20 0.39
PDE6G P18545 1/20 0.39
PDE6B P35913 1/20 0.39
PDE6C P51160 1/20 0.39
PDE6H Q13956 1/20 0.39
CSF1R P07333 1/20 0.38
PIM3 Q86V86 2/20 0.38
PLK4 O00444 1/20 0.38
DYRK3 O43781 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
CHEK2 O96017 1/20 0.38
FGFR1 P11362 1/20 0.38
CDK2 P24941 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
CLK2 P49760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3089753 0.84 THRB (0.44) THRBPDE6DPDE5APDE6APDE6G
SCHEMBL1644467 0.79 THRB (0.46) THRBPDE6DPDE5APDE6APDE6G
SCHEMBL1642916 0.78 CFTR (0.51) THRBPDE6DPDE5APDE6APDE6G
SCHEMBL27855175 0.78 CSF1R (0.51) THRBPDE6DPDE5APDE6APDE6G
SCHEMBL14378112 0.74 THRB (0.62) THRBPDE6DPDE5APDE6APDE6G
SCHEMBL1643224 0.72 PDE2A (0.39) THRBPDE6DPDE5APDE6APDE6G
SCHEMBL1285343 0.72 KDM4E (0.39)
SCHEMBL23967570 0.69 PARP1 (0.46) THRBPIM3PLK4DYRK3PRKD3
SCHEMBL438818 0.69 ALDH1A1 (0.53) THRBCSF1RPIM3PLK4DYRK3
SCHEMBL13544869 0.69 PARP1 (0.44) THRBPDE6DPDE5APDE6APDE6G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399673-B2 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-03-19 US disclosed
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators DRUNENTHAL GMBH (DE) 2012-10-04 US disclosed
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNJ2 THRB 2178/4885PDE6D 2433/4885PDE5A 1910/4885
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators KCNQ1, KCNQ2, KCNJ2 THRB 2178/4885PDE6D 2433/4885PDE5A 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.